Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries

Fig. 4

Rate of resolution of swollen joints (HR and 95% CI) after start of TNFi with additional adjustment for patient profiles with different joint involvement clusters in comparison to Fig. 3. The rate of resolution of synovitis for different comparisons (A, B, C) is estimated using overall interval-censored mixed-effects Cox proportional hazards models: A joints along the proximal–distal axis of the upper limb, B finger joints along the anterior–posterior axis of the hand (digits 1–5), C knee compared to elbow. The reference joint(s) are indicated in each panel. The numbers of swollen joints and of patients are shown for each joint location. MCP3 = metacarpophalangeal joint of digit 3; PIP3 = proximal interphalangeal joint of digit 3

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us